Have a personal or library account? Click to login
IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy Cover

IM botulinum toxin-A improves ambulation in severe haemophilia and cerebral palsy

Open Access
|Apr 2018

References

  1. 1. Carr LJ, Cosgrove AP, Gringas P, Neville BGR, on behalf of the UK Botulinum Toxin and cerebral palsy working party. Position paper on the use of botulinum toxin in cerebral palsy. Arch Dis Child 1998; 79: 271O27310.1136/adc.79.3.271
  2. 2. Delgado MR, Hirtz D, Aisen M, et al. Practice Parameter: Pharmocologic treatment of spasticity in children and adolescents with cerebral palsy Pan evidenceObased reviewQ Report of the quality standards subcommittee of the child neurology society. Neurology 2010; 74: 336O343.10.1212/WNL.0b013e3181cbcd2f
  3. 3. Love SC, Novak I, Kentish M, et al. Botulinum toxin assessment, intervention and after care for lower limb spasticity in children with cerebral palsy:international consensus statement. European J Neurol 2010, 17 PSupplQ 9O37.10.1111/j.1468-1331.2010.03126.x
  4. 4. Corry IS, Cosgrove AP, Duffy CM, et al. Botulinum toxin A compared with stretching casts in the treatment of spastic equines: a randomized prospective trial. J Ped Orthopaedics 1998, 18, 304O311.10.1097/01241398-199805000-00006
  5. 5. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994; 36: 386O396.10.1111/j.1469-8749.1994.tb11864.x
  6. 6. Graham HK, Aokia KR, AuttiORamob, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11: 67O79.10.1016/S0966-6362(99)00054-5
  7. 7. Ward A. LongOterm modifications of spasticity. J Rehabil Med 2003; 35: 60O65.
  8. 8. de Paiva A, Muenier FA, Molgo J, et al. Functional repair of motor endplates after botulinum neurotixin type A poisoning:biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 1999; 96: 3220O5.10.1073/pnas.96.6.32001591910077661
  9. 9. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. European J Neurol 1999; 6 PSupplQ: 23O35.10.1111/j.1468-1331.1999.tb00031.x
  10. 10. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practitioner 1964; 192: 540O542.
  11. 11. Palisanao R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39: 214O233.10.1111/j.1469-8749.1997.tb07414.x9183258
DOI: https://doi.org/10.17225/jhp.00020 | Journal eISSN: 2055-3390
Language: English
Page range: 21 - 23
Published on: Apr 21, 2018
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2018 Melanie Bladen, Karen Edwards, Kate Khair, Eleanor Main, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.